Stocktoria
HOYA Corporation 7741.T
JP · Tokyo Stock Exchange · XTKS · stock · Healthcare · website
HOYA Corporation financials (annual, from 10-K)
Bars are annual figures from 2023 to 2026; red bars are negative (a loss or cash outflow).
| Metric | FY2026 | FY2025 | FY2024 | FY2023 |
|---|---|---|---|---|
| Revenue | $995.8B | $885.8B | $792.6B | $734.1B |
| Gross profit | $859.9B | $766.3B | $688.0B | $631.9B |
| SG&A expense | $18.0B | $21.0B | $18.3B | $16.0B |
| Operating income | $551.1B | $480.8B | $433.5B | $400.9B |
| Interest expense | $2.0B | $1.5B | $1.9B | $1.8B |
| Income tax | $76.2B | $58.2B | $54.0B | $47.0B |
| Net income | $253.1B | $202.1B | $181.4B | $168.6B |
| EPS (diluted) | $743.82 | — | $515.27 | $469.47 |
| Operating cash flow | $278.4B | $235.1B | $222.8B | $201.8B |
| Free cash flow | $221.9B | $187.2B | $181.7B | $168.4B |
| Cash & equivalents | $574.1B | $534.0B | $525.2B | $405.9B |
| Inventory | $132.5B | $124.5B | $119.1B | $105.2B |
| Total assets | $1.30T | $1.23T | $1.20T | $1.03T |
| Total liabilities | $265.9B | $262.6B | $241.4B | $213.7B |
| Shareholders' equity | $1.02T | $974.0B | $967.8B | $818.3B |
Growth · year-over-year · Revenue CAGR 10.7%
| Metric | FY2026 | FY2025 | FY2024 | FY2023 |
|---|---|---|---|---|
| Revenue growth | +12.4% | +11.8% | +8.0% | — |
| Net income growth | +25.2% | +11.4% | +7.6% | — |
| EPS growth | — | — | +9.8% | — |
| Free cash flow growth | +18.5% | +3.0% | +7.9% | — |
Each column is the change versus the prior fiscal year. Growth off a negative or zero base is shown as “—”. CAGR is the compound annual revenue growth across the years shown.
Source: company filings via Yahoo Finance · JP · as of 2026-03-31. Figures in JPY; non-US fundamentals are aggregated by Yahoo (shorter history); facts plus Stocktoria's own computed scores — not investment advice.